Depression - A common disorder across a broad spectrum of neurological conditions: A cross-sectional nationally representative survey

General Hospital Psychiatry

Volumn 37, Issue 6, 2015, Pages 507-512

  Bulloch, Andrew G M ^a,b,c   Fiest, Kirsten M ^a,c   Williams, Jeanne V A ^a   Lavorato, Dina H ^a   Berzins, Sandra A ^a,c   Jetté, Nathalie ^a,c   Pringsheim, Tamara M ^c   Patten, Scott B ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Community based study; Depression rating scales; Depressive disorder; Neurological conditions; Prevalence

Indexed keywords

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN TUMOR; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; DEPRESSION; DYSTONIA; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PARKINSON DISEASE; PATIENT HEALTH QUESTIONNAIRE 9; PREVALENCE; SPINAL CORD TUMOR; SPINAL DYSRAPHISM; TRAUMATIC BRAIN INJURY; CANADA; COMORBIDITY; MENTAL DISORDERS; MIDDLE AGED; QUESTIONNAIRE;

CANADA; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; SURVEYS AND QUESTIONNAIRES;

EID: 84946479141     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2015.06.007     Document Type: Article

References (52)

1. Walker A.K., Kavelaars A., Heijnen C.J., Dantzer R. Neuroinflammation and comorbidity of pain and depression. Pharmacol Rev 2014, 66(1):80-101.
2. Oladeji B.D., Gureje O. The comorbidity between depression and diabetes. Curr Psychiatry Rep 2013, 9:390-398.
3. Moller-Leimkuhler A.M. Higher co-morbidity of depression and cardiovascular disease in women: a biopsychosocial perspective. World J Biol Psychiatry 2010, 11(8):922-933.
4. Bruce T.O. Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications. Curr Psychiatry Rep 2008, 10(3):258-264.
5. Soh S.-E., Morris M.E., McGinley J. Determinants of health-related quality of life in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 2011, 17:1-9.
6. Patten S.B., Williams J.V.A., Lavorato D.H., Mogdill G., Jette N., Eliasziw M. Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort. Gen Hosp Psychiatry 2008, 30:407-413.
7. Starkstein S.E., Merello M. Psychiatric and cognitive disorders in Parkinson's disease 2002, Cambridge University Press, Cambridge.
8. Fiest K.M., Dykeman J., Patten S.B., Wiebe S., Kaplan G.G., Maxwell C.J., et al. Depression in epilepsy: a systematic review and meta-analysis. Neurology 2013, 80:590-599.
9. Siegert R.J., Abernethy D.A. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005, 76:469-475.
10. Reijnders J.S., Ehrt U., Weber W.E., Aarsland D., Leentjens A.F. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008 Jan 30, 23:183-189.
11. Jorge R.E., Starkstein S.E. Pathophysiologic aspects of major depression following traumatic brain injury. J Head Trauma Rehabil 2005, 6:475-487.
12. Kroenke K., Spitzer R.L. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann 2002, 32:1-7.
13. Manea L., Gilbody S., McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9); a meta-analysis. CMAJ 2012, 184(3):E191-E196.
14. Kroenke K., Spitzer R.L., Williams J.B., Lowe B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry 2010 Jul, 32:345-359.
15. Fiest K.M., Patten S.B., Wiebe S., Bulloch A.G., Maxwell C.J., Jette N. Validating screening tools for depression in epilepsy. Epilepsia 2014, 55(10):1642-1650.
16. Patten S.B., Fiest K.M., Wiebe S., Bulloch A.G., Koch M., Dobson K.S., et al. The validity of four screenings scales for depression in MS. Mult Scler 2015, [in press].
17. Thompson A.W., Liu H., Hays R.D., Katon W.J., Rausch R., Diaz N., et al. Diagnostic accuracy and agreement across three depression assessment measures for Parkinson's disease. Parkinsonism Relat Disord 2011, 17:40-45.
18. Sjonnesen K., Berzins S., Fiest K.M., Bulloch A.G.M., Metz L.M., Thombs B.D., et al. Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with Multiple Sclerosis. Postgrad Med 2012, 124(5):69-77.
19. Sullivan M., Katon W., Russo J., Dobie R., Sakai C. A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms. Arch Intern Med 1993, 153(19):2251-2259.
20. Williams L.S. Depression and stroke: cause or consequence?. Semin Neurol 2005, 25(4):396-409.
21. Mohr D.C., Goodkin D.E., Likosky W., Gatto N., Baumann K.A., Rudick R.A. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol 1997, 54(5):531-533.
22. DiMatteo M.R., Lepper H.S., Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160(14):2101-2107.
23. Wang J.L., Reimer M.A., Metz L.M., Patten S.B. Major depression and quality of life in individuals with multiple sclerosis. Int J Psychiatry Med 2000, 30(4):309-317.
24. Jau-Shin L., Reeves A., Benice T., Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology 2003, 60:122-123.
25. Ben-Shlomo Y., Camfield L., Warner T. What are the determinants of quality of life in people with cervical dystonia?. J Neurol Neurosurg Psychiatry 2002, 72(5):608-614.
26. Boylan L.S., Flint L.A., Labovitz D.L., Jackson S.C., Starner K., Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004, 62(2):258-261.
27. Bronnum-Hansen H., Stenager E., Nylev Stenager E., Koch-Henriksen N. Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatry 2005, 76(10):1457-1459.
28. Viner R., Patten S.B., Berzins S., Bulloch A.G.M., Fiest K.M. Prevalence and risk factors for suicidal ideation in a multiple sclerosis population. J Psychosom Res 2014, 76:312-316.
29. Jones J.E., Hermann B.P., Barry J.J., Gilliam F.G., Kanner A.M., Meador K.J. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav 2003, 4(Suppl. 3):S31-S38.
30. Farrer L.A. Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk. Am J Med Genet 1986, 24(2):305-311.
31. Survey of Living with Neurological Conditions in Canada (SLNCC) Statistics Canada, [Last updated: 12-11-2012, Date accessed: 8-23-2013]. http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=5182&Item_Id=845.
32. Noonan V.K., Fingas M., Farry A., Baxter D., Singh A., Fehlings M.G., et al. Incidence and prevalence of spinal cord injury in Canada: a national perspective. Neuroepidemiology 2012, 38:219-226.
33. Kessler R.C., Andrews G., Mroczek D., Ustun B., Wittchen H-U., et al. The World Health Organization Composite International Diagnostic Interview Short-Form (CIDI-SF). Int J Methods Psychiatr Res 1998, 7:171-185.
34. Table 105-1300. Neurological conditions, by age group and sex, household population aged 0 and over, 2010/2011 Statistics Canada, [Last updated: 9-18-2012, Date accessed: 8-23-2013]. http://www5.statcan.gc.ca/cansim/pick-choisir?lang=eng&p2=33&id=1051300.
35. Payne J.L., Sheppard J-M E., Steinberg M., Warren A., Baker A., Steele C., et al. Incidence, prevalence, outcomes of depression in residents of a long-term care facility with dementia. Int J Geriatr Psychiatry 2002, 17:245-253.
36. Miller K.M., Okun M.S., Fernandez H.F., Jacobson C.E., Rodriguez R.L., Bowers D. Depression symptoms in movement disorders: comparing Parkinson's disease, dystonia, and essential tremor. Mov Disord 2007, 22(5):666-672.
37. Lewis L., Butler A., Jahanshahi M. Depression in focal, segmental and generalized dystonia. J Neurol 2008, 255:1750-1755.
38. Starkstein S.E., Merello M., Jorge R., Brockman S., Bruce D., Petracca G., et al. A validation study of depressive symptoms in Parkinson's disease. Mov Disord 2008, 23(4):546-583.
39. Jorge R.E., Starkstein S.E. Pathophysiologic aspects of major depression following traumatic brain injury. J Head Trauma Rehabil 2005, 20(6):475-487.
40. Hart T., Hoffman J.M., Pretz C., Kennedy R., Clark A.N., Brenner L.A. A longitudinal study of major and minor depression following traumatic brain injury. Arch Phys Med Rehabil 2012, 83:1343-1349.
41. Paolucci S. Epidemiology and treatment of post-stroke depression. Neuropsychiatr Dis Treat 2008, 4(1):145-154.
42. Mainio A., Hakko H., Niemela A., Koivukangas J., Rasanen P. Depression in relation to anxiety, obsessionality and phobia among neurosurgical patients with a primary tumor: a 1-year follow-up study. Clin Neurol Neurosurg 2011, 113:649-653.
43. Pelletier G., Verhoef M.J., Khatri N., Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol 2002, 57:41-49.
44. Wellisch D.K., Kalieta T.A., Freeman D., Cloughesy T., Goldman J. Predicting major depression in brain tumor patients. Psycho-Oncology 2002, 11:230-238.
45. Zunzain P.A., Hepgul N., Pariante C.M. Inflammation and depression. Curr Topics Behav Neurosci 2013, 14:135-151.
46. Hermida A.P., McDonald W.M., Steenland K., Levey A. The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?. Expert Rev Neurother 2012, 12(11):1339-1356.
47. Pascoe M.C., Crewther S.G., Carey L.M., Crewther D.P. Inflammation and depression: why poststroke depression may be the norm and not the exception. Int J Stroke 2011, 6:128-135.
48. Fenn A.M., Gensel J.C., Huang Y., Popovich P.G., Lifshitz J., Godbout J.P. Immune activation promotes depression 1 month after diffuse brain injury: a role for primed microglia. Biol Psychiatry 2014, 76(7):575-584.
49. Vezzani A. Epilepsy and inflammation in the brain: overview and pathophysiology. Curr Rev Clin Sci 2014, 14((1) Suppl.):3-7.
50. Poole L., Dickens C., Steptoe A. The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation. J Psychosom Res 2011, 71:61-68.
51. Tellez-Zenteno J.F., Pondal-Sordo M., Matijevic S., Wiebe S. National and regional prevalence of self-reported epilepsy in Canada. Epilepsia 2004, 45:1623-1629.
52. Brooks D.R., Avetisyan R., Jarrett K.M., et al. Validation of self-reported epilepsy for purposes of community surveillance. Epilepsy Behav 2012, 23:57-63.